Please login to the form below

Not currently logged in
Email:
Password:

Idea Pharma taps Astellas and Xention for new recruits

The phase II strategy consultancy appoints four new members of staff, including Astellas’ Amy Wasserman and Xention’s Calum Graham

Phase II strategy consultancy Idea Pharma has appointed four new members of staff, including Astellas' Amy Wasserman and Xention's Calum Graham.

Wasserman joins Idea Pharma as director of client value (US) after more than four years at Astellas Pharma US and before that stints at Janssen-Ortho and Solvay.

Meanwhile, Graham has over 20 years' pharma experience, including two years with Xention as director of business development. Prior to that he spent six years at GlaxoSmithKline leading global studies across a wide range of therapeutic areas.

Idea Pharma has also appointed Tristan Allen as European account manager and Claire Hales as office administrator (UK).

Allen was most recently an independent marketing and business development consultant while Hales joins Idea Pharma from the steel coating industry.

14th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics